News about Market

Takeda Becomes a BaseLaunch Partner

BaseLaunch has added Takeda as a new pharmaceutical partner to its biotech venture incubator, expanding its network of global pharma backers supporting and funding early-stage drug development startups.

Market | 19/12/2025 | By News Bureau |  189

Zydus Lifesciences Inks Exclusive Deal with Myriad Genetics for Cancer Risk Tests in India

Zydus Lifesciences has entered into an exclusive agreement with US-based Myriad Genetics to introduce clinically validated cancer-risk assessment diagnostic tests in India, aimed at enabling personalised, evidence-based cancer care and strengthening early detection and preventive oncology efforts in the country.

Market | 19/12/2025 | By News Bureau |  207

Pfizer and Cipla Form Exclusive Marketing Partnership for Select Brands in India

Pfizer and Cipla have joined forces in an exclusive marketing and distribution agreement for select brands in India. The collaboration aims to improve access and availability of these key medicines, ensuring patients across the country benefit from a wider reach and streamlined supply.

Market | 19/12/2025 | By News Bureau |  340

Lupin Inks Exclusive Licensing Deal with Neopharmed for Plasil in Brazil and Philippines

Global pharmaceutical major Lupin Limited said its subsidiaries in the Philippines, Multicare Pharmaceuticals, and in Brazil, MedQuimica, have entered into an exclusive licensing agreement with Italy-based Neopharmed Gentili S.p.A. to market and promote the gastroenterology brand Plasil (metoclopramide) in their respective markets.

Market | 19/12/2025 | By Darshana |  393

Nona Biosciences and Valink Partner to Advance Biologics Discovery

Nona Biosciences and Valink Therapeutics have partnered to advance biologics discovery by combining Nona’s Harbour Mice fully human antibody technologies, including heavy chain-only antibodies, with Valink’s LiliumX discovery platform to generate and screen thousands of novel drug candidates.

Market | 18/12/2025 | By News Bureau |  221

Alembic Pharma Wins USFDA Approval for Travoprost Ophthalmic Solution

Alembic Pharmaceuticals has secured USFDA approval for its Travoprost Ophthalmic Solution, with the ANDA deemed therapeutically equivalent to the reference listed drug Travatan Z (0.004%) from Sandoz.

Market | 18/12/2025 | By News Bureau |  181

Senores Pharmaceuticals to Acquire Apnar Pharma and Five ANDAs

Senores Pharmaceuticals has entered into an agreement to acquire 100 percent equity in Apnar Pharma, along with a portfolio of five Abbreviated New Drug Applications (ANDAs), as part of its strategy to expand its footprint in regulated pharmaceutical markets.

Market | 18/12/2025 | By Darshana |  273

Sathgen Therapeutics Expands Global Footprint with US Subsidiary Launch

Sathgen Therapeutics has expanded its global presence with the launch of a US-based subsidiary, appointing Dr Padmaja Ganpathy as Chief Executive Officer and Dr Sendurai Mani as Chief Scientific Officer to lead its next phase of growth and innovation.

Market | 18/12/2025 | By News Bureau |  370

Lupin Secures Positive CHMP Opinion for Ranibizumab Biosimilar

Lupin has received a positive opinion from the CHMP for its ranibizumab biosimilar, supported by comprehensive analytical similarity data and a global Phase III clinical trial involving 600 patients with neovascular Age-related Macular Degeneration (AMD).

Market | 18/12/2025 | By News Bureau |  222

Indian Pharma Exports Rise Over Nine Percent in 2024-25: Government

India’s pharmaceutical exports recorded strong growth in the 2024–25 financial year, increasing by over nine percent to about USD 30.47 billion, according to government data.

Market | 18/12/2025 | By Darshana |  792